ursodeoxycholic acid has been researched along with Cirrhosis, Liver in 136 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (7.35) | 18.7374 |
| 1990's | 27 (19.85) | 18.2507 |
| 2000's | 36 (26.47) | 29.6817 |
| 2010's | 45 (33.09) | 24.3611 |
| 2020's | 18 (13.24) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, JC; Tu, LL; Yin, LN; Zhang, Y; Zhang, YW; Zheng, GL | 1 |
| Aishima, S; Eguchi, Y; Higurashi, T; Honda, A; Honda, Y; Hosono, K; Hyogo, H; Imajo, K; Iwaki, M; Kage, M; Kasai, Y; Kato, S; Kawaguchi, T; Kawanaka, M; Kessoku, T; Kobayashi, N; Kobayashi, T; Nakajima, A; Nogami, A; Ogawa, Y; Oyamada, S; Ozaki, A; Saito, S; Shinoda, S; Sumida, Y; Takahashi, H; Takahashi, K; Tanaka, K; Torimura, T; Usuda, H; Wada, K; Yamamoto, A; Yoneda, M | 1 |
| Adekunle, F; Battezzati, PM; Bowlus, CL; Bruns, T; Carbone, M; Cazzagon, N; Corpechot, C; Dalekos, GN; Fisher, H; Flack, S; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Hirschfield, GM; Hiu, S; Invernizzi, P; Janssen, HLA; Jones, D; Kareithi, D; Kowdley, KV; Lammers, WJ; Lindor, KD; Lleo, A; Londoño, MC; Malecha, E; Mason, AL; Mayne, T; Mayo, MJ; Mells, G; Mulcahy, V; Murillo Perez, CF; Ness, E; Nevens, F; Parés, A; Smith, R; Thorburn, D; Trauner, M; Trivedi, PJ; van der Meer, AJ; Verhelst, X; Wason, J | 1 |
| Chai, J; Fu, L; Peng, S; Tao, L; Wang, H; Zhang, J; Zhang, X; Zhao, N; Zhou, Z | 1 |
| Corpechot, C | 1 |
| Racila, A; Stepanova, M; Younossi, I; Younossi, ZM | 1 |
| Bastaich, D; Brevini, T; Chao, HH; Chin, AM; Dahman, B; Deng, Y; Ferreira, RD; John, BV; Kaplan, DE; Mahmud, N; Moon, A; Sampaziotis, F; Serper, M; Taddei, TH; Webb, G | 1 |
| Liu, L; Lu, W; Mo, G; Qiao, F; Ren, F; Wang, S; Xu, X; Yang, H | 1 |
| Bassi, M; Muzahim, Y; Pyrsopoulos, N; Wakil, A | 1 |
| Russo, MW; Wheless, WH | 1 |
| Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ | 1 |
| Lee, HW; Lee, JI; Lee, KS | 1 |
| Bruns, T; Carbone, M; Corpechot, C; Dalekos, GN; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Maria Battezzati, P; Mason, AL; Mayo, MJ; Murillo Perez, CF; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, A; Verhelst, X | 1 |
| Gulamhusein, AF; Hirschfield, GM | 1 |
| Chen, L; Chen, XZ; Wu, PB; Ye, HL; Zhang, G; Zhang, JW | 1 |
| Battezzati, PM; Buuren, HRV; Corpechot, C; de Veer, RC; Floreani, A; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Pares, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, AJ | 1 |
| Ferenci, P; Halilbasic, E; Stättermayer, AF; Trauner, M; Wrba, F | 1 |
| Atkin, SL; De Vincentis, A; Jamialahmadi, T; Mahjoubin-Tehran, M; Mantzoros, CS; Mikhailidis, DP; Sahebkar, A | 1 |
| Bergquist, A; Beuers, U; Drebber, U; Färkkilä, M; Greinwald, R; Hirschfield, GM; Kupcinskas, L; Manns, MP; Ott, P; Parés, A; Poupon, R; Pröls, M; Spengler, U; Stiess, M; Wendum, D | 1 |
| Dong, X; Lu, S; Luo, Y; Ma, H; Sun, G; Sun, X; Zhang, W; Zhu, Y | 1 |
| Chesnokov, E; Ivashkin, V; Kaibullayeva, J; Khamrabaeva, F; Kodzoeva, K; Konysbekova, A; Maevskaya, M; Nadinskaia, M; Nersesov, A; Pirogova, I; Raissova, A; Zueva, E | 1 |
| Mehtiyev, SN; Mehtiyeva, OA | 1 |
| De Silva, AP; de Silva, HJ; Gunathilaka, ML; Luke, NV; Niriella, MA; Piyarathna, CL; Siriwardena, RC | 1 |
| Bae, JS; Cha, JY; Hahm, KB; Han, YM; Ko, KH; Lee, HJ; Oh, BC; Park, JM | 1 |
| Alaca, N; Çağlayan Yeğen, B; Kurtel, H; Öktem, G; Özbeyli, D; Şahin, HH; Uslu, S; Yiğittürk, G | 1 |
| Liang, Q; Liu, Z; Shi, Y; Tang, N; Zhang, Y | 1 |
| Jeong, SH | 1 |
| Aziz, K; Breton, E; Chailloux, P; Cousin, E; Cousin, I | 1 |
| Almishri, W; Frolkis, AD; Kaplan, GG; Patten, S; Shaheen, AA; Swain, MG; Vallerand, I | 1 |
| Baumann, U; Beerbaum, P; Hohmann, D; Junge, C; Junge, N; Leiskau, C; Pfister, ED; Schröder, J | 1 |
| Chen, CY; Lin, NC; Liu, C; Liu, CP; Tsai, HL; Yeh, YC; Yeh, YT | 1 |
| Brunet, E; Casas, M; Dalmau, B; Hernández, L; Miquel, M; Sánchez-Delgado, J; Valero, O; Vergara, M | 1 |
| Ben Mansour, W; Bouhlel, W; Guediche, A; Jemmali, D; Loghmari, MH; Safer, L | 1 |
| Aguilera, L; Albillos, A; Martínez, J | 1 |
| Ge, GH; Gong, YH; Ji, HL; Lu, ZH; Sheng, JH; Sun, L; Tan, YW; Zhou, XB | 1 |
| Aguesse, A; Boursier, J; Chaigneau, J; Coué, M; Croyal, M; Falewée, J; Fizanne, L; Ouguerram, K; Tesse, A | 1 |
| Bolan, C; Cortese, C; Harnois, D; Mallea, J | 1 |
| Hou, XH; Li, AH; Li, L; Pan, XL; Xu, KS; Yang, L; Ye, J; Zhao, L | 1 |
| Chamulitrat, W; Ludwig, JM; Mueller, J; Pathil, A; Stremmel, W; Wang, J; Warth, A | 1 |
| Claudel, T; Engelmann, R; Fickert, P; Fuchs, CD; Guenther, ND; Langner, C; Loebermann, M; Mueller, M; Mueller-Hilke, B; Österreicher, CH; Reisinger, EC; Sahin, E; Schramm, C; Schwinge, D; Sombetzki, M; Trauner, M | 1 |
| Joshita, S; Kimura, T; Komatsu, M; Matsumoto, A; Ota, M; Sekiguchi, T; Shibata, S; Tanaka, E; Umemura, T; Usami, Y | 1 |
| Akyol, G; Callea, F; Dalgic, B; Francalanci, P; Giovannoni, I; Gonul, II; Sari, S; Yilmaz, G | 1 |
| Aihara, Y; Douhara, A; Kawaratani, H; Kitade, M; Moriya, K; Namisaki, T; Nishimura, N; Noguchi, R; Okura, Y; Seki, K; Takaya, H; Takeda, K; Yoshiji, H | 1 |
| Alonso, EM; Harned, R; Karmazyn, B; Krishnamurthy, R; Leung, DH; Ling, S; Magee, JC; Marshall, BC; Molleston, JP; Murray, KF; Narkewicz, MR; Palermo, J; Paranjape, SM; Romero, R; Schwarzenberg, SJ; Sherker, AH; Siegel, MJ; Weymann, A; Ye, W | 1 |
| Blomenkamp, K; Fickert, P; Marcus, N; Tang, Y; Teckman, J; Trauner, M | 1 |
| Houwen, RH; van der Doef, HP; van der Ent, CK; van der Feen, C | 1 |
| He, P; Lei, JH; Wang, CX; Yuan, WG; Zhang, CY | 1 |
| Abel, T; Fehér, J | 1 |
| Dienes, HP; Frenzel, C; Galle, PR; Herkel, J; Kanzler, S; Kasper, HU; Lohse, AW; Lüth, S; Schramm, C | 1 |
| Gordon, FD; Jenkins, R; Khettry, U; Lewis, WD; McPartland, KJ; Pomfret, EA; Pomposelli, JJ | 1 |
| Bellot, P; Berzigotti, A; Bosch, J; De Gottardi, A; Gagnon, C; Garcia-Pagan, JC; Spénard, J | 1 |
| Li, N; Li, Y; Shen, S; Wang, X | 1 |
| Baussan, C; Bernard, O; Branchereau, S; Davit-Spraul, A; Fabre, M; Gonzales, E; Jacquemin, E; Stieger, B | 1 |
| El Koundi, H; Errabih, I; Fadlouallah, M; Jahid, A; Krami, H; Lahmiri, M; Mahassini, N; Ouazzani, H; Tahri, S; Tamzaourte, M | 1 |
| Dockter, G; Herrmann, U; Lammert, F | 1 |
| Boberg, KM; Karlsen, TH; Schrumpf, E | 1 |
| Beraza, N; Bischoff, SC; Boekschoten, M; Ehedego, H; Mueller, M; Ofner-Ziegenfuss, L; Trauner, M; Trautwein, C | 1 |
| Colombo, C; Consonni, D; Costantino, L; Coviello, DA; Degiorgio, D; Maggiore, G; Motta, V; Tornillo, L; Vajro, P | 1 |
| Álvarez Ferre, J; González Jiménez, E; Schmidt Río-Valle, J | 1 |
| Fauler, G; Fickert, P; Frank, S; Guelly, C; Gumhold, J; Höfler, G; Kratky, D; Lass, A; Magnes, C; Moustafa, T; Reicher, H; Sattler, W; Silbert, D; Sinner, F; Thueringer, A; Trauner, M; Zechner, R | 1 |
| Hino-Arinaga, T; Hisamochi, A; Ide, T; Kuromatsu, R; Kuwahara, R; Miyajima, I; Ogata, K; Sata, M; Torimura, T | 1 |
| Ko, K; Lu, SC; Ramani, K; Tomasi, ML; Yang, H | 1 |
| Choi, MK; Han, JM; Hwang, SY; Kim, HG; Lee, JS; Park, HJ; Son, CG; Son, SW; Wang, JH | 1 |
| Ando, M; Anzai, T; Asagi, A; Hirohata, M; Miyake, Y; Miyatake, H; Moriya, A; Nakatsu, M; Yasuhara, H | 1 |
| Duggan, C; Raphael, BP | 1 |
| Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Chazouillères, O; Heathcote, EJ; Lindor, KD; Parés, A; Poupon, R; Poupon, RE | 1 |
| Antonelli, E; Fiorucci, S; Morelli, A | 1 |
| Iinuma, Y; Kanada, S; Kinoshita, Y; Kubota, M; Yagi, M; Yamazaki, S | 1 |
| Acuto, G; Antonelli, E; Baldoni, M; Brancaleone, V; Clerici, C; Del Soldato, P; Distrutti, E; Fiorucci, S; Morelli, A; Orlandi, S; Sanpaolo, L | 1 |
| Cadelina, GW; Groszmann, RJ; Iwakiri, Y; Loureiro-Silva, MR | 1 |
| Chrétien, Y; Corpechot, C; Galotte, M; Poujol-Robert, A; Poupon, R; Poupon, RE; Wendum, D | 1 |
| Yamada, G | 1 |
| Blum, HE | 1 |
| Blum, HE; Kreisel, W; Opitz, OG; Thimme, R | 1 |
| Fujiyama, S; Hirokawa, S; Masaki, T; Miyakawa, K; Ohkawa, S; Tamai, S; Tanaka, K; Tarao, K | 1 |
| Färkkilä, M; Kärkkäinen, P; Karvonen, AL; Nurmi, H; Nuutinen, H; Pikkarainen, P; Rautiainen, H | 1 |
| Chapman, RW; Cullen, SN | 1 |
| Vierling, JM | 1 |
| Copaci, I; Iliescu, L; Micu, L; Voiculescu, M | 1 |
| Hu, QW; Liu, GT | 1 |
| Beuers, U; Pusl, T | 1 |
| Paumgartner, G | 1 |
| Bihl, F; Cereda, JM; Cerny, A; Dufour, JF; Gonvers, JJ; Helbling, B; Oneta, CM; Steuerwald, M; Zala, JF; Zimmermann, A | 1 |
| Rockey, DC | 1 |
| Houwen, RH; Stapelbroek, JM; van de Nadort, C | 1 |
| Alexander, GJ; Allison, ME; Bilton, D; Haworth, CS; Lomas, DJ; McKeon, D; Nash, KL | 1 |
| García-Buey, L; Gisbert, JP; Gómez-Dominguez, E; Jones, EA; Mendoza, J; Moreno-Otero, R; Trapero, M | 1 |
| Comert, B; Mas, MR; Mas, N; Ocal, R; Tasci, I | 1 |
| Miescher, G; Paumgartner, G; Preisig, R | 1 |
| Beppu, T; Futagawa, S; Murata, N; Sugiura, M; Ushiyama, K; Wada, T | 1 |
| Imawari, M; Matsuzaki, Y; Mitamura, K; Osuga, T; Shoda, J | 1 |
| Iida, S; Ikawa, S; Makino, I; Ohkubo, H; Ohnishi, K; Okuda, K | 1 |
| Hirayama, C; Ikawa, S; Kawasaki, H; Kishimoto, Y; Yamanishi, Y | 1 |
| Doss, MO; Frank, M | 1 |
| Abdelmalek, M; Lindor, KD; Ludwig, J | 1 |
| Bernard, O; Estrada, A; Hadchouel, M; Jacquemin, E; Maggiore, G; O'Connell, NC; Schmitz, J; Setchell, KD | 1 |
| Bianchi, L; Reichen, J | 1 |
| Akiyama, K; Aoshima, Y; Fujita, M; Hasegawa, T; Hotta, H; Kato, T; Kimura, A; Makino, T; Nakamura, K; Nishimura, H | 1 |
| Buongiorno, G; Guerra, V; Manghisi, OG; Misciagna, G; Penna, A; Quaranta, GM | 1 |
| Anagnostopoulos, C; Feigelson, J; Munck, A; Navarro, J; Pecau, Y; Poquet, M | 1 |
| Bianchi, G; Gatta, A; Iervese, T; Magalotti, D; Marchesini, G; Merkel, C; Pisi, E; Zoli, M | 1 |
| Parés, A; Rodés, J | 1 |
| Andoh, Y; Beck, Y; Gotoh, M; Kita, Y; Monden, M; Nagao, T; Sakon, M; Teraoka, S; Yokota, K | 1 |
| Chazouillères, O; Haniche, M; Jian, R; Marteau, P; Poupon, R | 1 |
| Motoo, Y; Okai, T; Sawabu, N; Taga, H; Watanabe, H; Yamaguchi, Y | 1 |
| Jonas, MM; Perez-Atayde, A; Srivastava, M | 1 |
| Angulo, P; Batts, KP; Dickson, ER; Jorgensen, RA; Lindor, KD; Therneau, TM | 1 |
| Allard, J; Blendis, L; Bomzon, A; Liu, P; Wong, F | 1 |
| Inaba, K; Ishikawa, H; Kashima, K; Mitsuyoshi, H; Nakajima, Y; Nakashima, T; Sakai, M; Sakamoto, Y; Shima, T | 1 |
| García, N; Martí-Climent, JM; Medina, JF; Peñuelas, I; Prieto, J; Richter, JA | 1 |
| Assy, N; Baruch, Y; Blendis, LM; Bomzon, A; Enat, R; Reisner, SA; Rinkevich, D; Weisbruch, F | 1 |
| Beccarello, A; Bortolato, L; Ceselli, S; Crepaldi, G; Crovatto, M; Lirussi, F; Morselli-Labate, AM; Santini, G | 1 |
| Angulo, P; Batts, KP; Larson, DR; LaRusso, NF; Lindor, KD; Therneau, TM | 1 |
| Carpenter, HA; Czaja, AJ; Lindor, KD | 1 |
| Harada, H; Kamitsukasa, H; Kojima, H; Murai, S; Tokita, H; Yagura, M | 1 |
| Kumar, KS; Malet, PF | 1 |
| Bonnand, AM; Carrat, F; Corpechot, C; Poupon, R; Poupon, RE | 1 |
| Kobayashi, M; Koike, M; Kurosawa, T; Murai, T; Nittono, H; Okuda, M; Okuda, S; Sakiyama, M; Takei, H; Tanaka, T; Unno, A; Yoshimura, T | 1 |
| Kakisaka, Y; Mitsuyoshi, H; Nakashima, T; Sumida, Y; Yoh, T | 1 |
| Antonelli, E; Casini, A; del Soldato, P; Fiorucci, S; Mello, T; Mencarelli, A; Morelli, A; Morelli, O; Palazzetti, B; Tallet, D | 1 |
| Tarao, K | 1 |
| Blechacz, B; Herrmann, T; Mueller, S; Rost, D; Stremmel, W | 1 |
| Crétel, E; Durand, JM; Genty, I; Graffin, B; Jean, R | 1 |
| Lirussi, F; Okolicsanyi, L | 1 |
| Buongiorno, G; Guerra, V; Manghisi, OG; Misciagna, G; Quaranta, GM | 1 |
| Akiyama, K; Aoshima, M; Fugita, M; Hasegawa, T; Kato, T; Kimura, A; Makino, I; Nakamura, K; Tani, M | 1 |
| Jansen, PL | 1 |
| Rojkind, M | 1 |
| Hasegawa, T; Kashima, K; Nakajima, T; Nakashima, T; Okuno, T; Sakamoto, Y; Sano, A; Seto, Y; Shima, T | 1 |
| Bäcker, U; Doss, MO; Meessen, D; Schmidt, FW; Wagner, S; Wittekind, C | 1 |
| Ban, N; Kawasaki, T; Kimura, T; Moriyasu, F; Nakamura, T; Ono, S; Tamada, T; Uchino, H; Yamashita, Y | 1 |
| Iijima, T; Nambu, M | 1 |
| Hirayama, C; Kadohara, M; Kawasaki, H | 1 |
| Luciani, A; Massari, M; Montanari, P; Nora, A; Zandomeneghi, R | 1 |
35 review(s) available for ursodeoxycholic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis.
Topics: Fibrosis; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Treatment of Primary Biliary Cholangitis including Transplantation.
Topics: Cholagogues and Choleretics; Cholangitis; Female; Fibric Acids; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2024 |
Treatment of Primary Sclerosing Cholangitis Including Transplantation.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Cirrhosis; Liver Transplantation; Ursodeoxycholic Acid | 2024 |
Crosstalk network among multiple inflammatory mediators in liver fibrosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid | 2019 |
Primary biliary cholangitis: pathogenesis and therapeutic opportunities.
Topics: Adaptive Immunity; Animals; Autoimmunity; Bile Acids and Salts; Chenodeoxycholic Acid; Chloride-Bicarbonate Antiporters; Cholagogues and Choleretics; Dihydrolipoyllysine-Residue Acetyltransferase; Disease Progression; Environmental Exposure; Epigenesis, Genetic; Humans; Immunity, Innate; Liver Cirrhosis; Liver Cirrhosis, Biliary; MicroRNAs; Organic Anion Transporters, Sodium-Dependent; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Symporters; Ursodeoxycholic Acid | 2020 |
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; Bile Duct Neoplasms; Chemical and Drug Induced Liver Injury; Cholelithiasis; Cholestasis, Intrahepatic; Female; Gallbladder Neoplasms; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2020 |
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis.
Topics: Biopsy; Disease Progression; Humans; Liver; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E | 2021 |
[[New Paradigm Challenges of Steatosis Treatment in the Practice Therapist].]
Topics: Adult; Drug Combinations; Fatty Liver; Glycyrrhizic Acid; Humans; Liver Cirrhosis; Liver Function Tests; Male; Phosphatidylcholines; Practice Patterns, Physicians'; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2016 |
Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter.
Topics: Animals; Carcinoma, Hepatocellular; Drug Design; Fatty Acids, Omega-3; Humans; Immunoglobulins; Liver Cirrhosis; Liver Neoplasms; Membrane Proteins; Membrane Transport Proteins; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Tocotrienols; Ursodeoxycholic Acid | 2017 |
Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea.
Topics: Anti-Inflammatory Agents; Hepatitis, Autoimmune; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Prednisolone; Prevalence; Republic of Korea; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Risk stratification and treatment of primary biliary cholangitis.
Topics: Adult; Age Factors; Alkaline Phosphatase; Biomarkers; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Fibric Acids; Glucocorticoids; Humans; Liver Cirrhosis; Liver Transplantation; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure; Ursodeoxycholic Acid | 2019 |
Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; Bile Ducts, Intrahepatic; Biopsy; Cholestasis, Intrahepatic; DNA Mutational Analysis; Female; gamma-Glutamyltransferase; Genetic Testing; Humans; Liver; Liver Cirrhosis; Ursodeoxycholic Acid | 2018 |
Cystic Fibrosis-Associated Liver Disease in Lung Transplant Recipients.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Incidence; Liver Cirrhosis; Liver Transplantation; Lung Transplantation; Mutation; Postoperative Care; Quinolones; Survival Rate; Transplant Recipients; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; CD4-Positive T-Lymphocytes; Disease Progression; Fatty Liver, Alcoholic; Hepatic Stellate Cells; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; LIM Domain Proteins; Liver Cirrhosis; Macrophages; MicroRNAs; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Resveratrol; Schistosomiasis; Signal Transduction; Stilbenes; T-Lymphocytes, Regulatory; Triterpenes; Ursodeoxycholic Acid; Ursolic Acid; Virus Diseases | 2016 |
[Non-alcoholic fatty liver disease and cardiovascular risk].
Topics: Antioxidants; Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cytokines; Exercise; Fatty Acids, Nonesterified; Fatty Liver; Feeding Behavior; Humans; Insulin Resistance; Life Style; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Metabolic Syndrome; Obesity; Triglycerides; Ursodeoxycholic Acid | 2008 |
Cystic fibrosis-associated liver disease.
Topics: Animals; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Portasystemic Shunt, Transjugular Intrahepatic; Ursodeoxycholic Acid | 2010 |
Primary sclerosing cholangitis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangiography; Cholangitis, Sclerosing; Comorbidity; Disease Progression; Gallbladder Neoplasms; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Inflammatory Bowel Diseases; Linkage Disequilibrium; Liver Cirrhosis; Liver Transplantation; Practice Guidelines as Topic; Prognosis; Risk Factors; Ursodeoxycholic Acid | 2010 |
[Fatty liver and its clinical management in obese adolescents].
Topics: Adiponectin; Adolescent; Apoptosis; Biomarkers; Chemokines; Disease Progression; Fatty Liver; Fibrosis; Hepatocytes; Humans; Hypertriglyceridemia; Insulin Resistance; Kupffer Cells; Liver Cirrhosis; Liver Transplantation; Metformin; Models, Biological; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E | 2011 |
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.
Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid | 2003 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
[Hepatitis 2004: an update].
Topics: Antiviral Agents; Biopsy; Cholagogues and Choleretics; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Hepatitis, Alcoholic; Humans; Laparoscopy; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Physical Examination; Ultrasonography; Ursodeoxycholic Acid; Weight Loss | 2004 |
[Cholestatic liver diseases].
Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid | 2004 |
Review article: current management of primary sclerosing cholangitis.
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Combined Modality Therapy; Endoscopy, Digestive System; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Failure; Liver Transplantation; Stents; Ursodeoxycholic Acid | 2005 |
Future Treatment Options in PBC.
Topics: Autoimmunity; Cell Movement; Cell Proliferation; Cholagogues and Choleretics; Combined Modality Therapy; Disease Progression; Enzyme Inhibitors; Humans; Immunoglobulins; Immunotherapy; Inflammation; Liver Cirrhosis; Liver Cirrhosis, Biliary; Oxidation-Reduction; T-Lymphocytes; Ursodeoxycholic Acid | 2005 |
New therapeutical indications of ursodeoxycholic acid.
Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Female; Hepatocytes; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Mitochondria, Liver; Oxidative Stress; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2005 |
[Advances in the research of anti-hepatic fibrosis drugs].
Topics: Animals; Biphenyl Compounds; Drugs, Chinese Herbal; Genetic Therapy; Hepatocyte Growth Factor; Hepatocytes; Humans; Liver Cirrhosis; Plants, Medicinal; Ursodeoxycholic Acid | 2006 |
Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Topics: Apoptosis; Bile Acids and Salts; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis; Liver Failure; Syndrome; Ursodeoxycholic Acid | 2006 |
Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.
Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Cholestasis, Intrahepatic; Chronic Disease; Hepatocytes; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2006 |
New therapies in hepatitis C virus and chronic liver disease: antifibrotics.
Topics: Colchicine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-gamma; Interleukin-10; Liver Cirrhosis; Phosphatidylcholines; Silymarin; Ursodeoxycholic Acid | 2006 |
[Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Female; Graft vs Host Disease; Hepatitis; Hepatitis, Alcoholic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 1996 |
Nonalcoholic steatohepatitis.
Topics: Age Factors; Biopsy; Child; Cholagogues and Choleretics; Diabetes Complications; Disease Progression; Fatty Liver; Hepatitis; Humans; Hyperlipidemias; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Obesity; Ursodeoxycholic Acid | 2000 |
[Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C].
Topics: Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Glycine; Glycyrrhetinic Acid; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Risk; Treatment Outcome; Ursodeoxycholic Acid | 2001 |
[Therapy of alcoholic and non-alcoholic fatty liver].
Topics: Anti-Infective Agents; Antioxidants; Cholagogues and Choleretics; Clinical Trials as Topic; Diagnosis, Differential; Diet, Reducing; Exercise; Fatty Liver; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Hypolipidemic Agents; Lipotropic Agents; Liver Cirrhosis; Liver Function Tests; Risk Factors; Ursodeoxycholic Acid | 2001 |
Antifibrotic therapy of liver cirrhosis, with special reference to primary biliary cirrhosis: promises and limitations.
Topics: Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1992 |
Fibrogenesis in cirrhosis. Potential for therapeutic intervention.
Topics: Animals; Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Ursodeoxycholic Acid | 1992 |
18 trial(s) available for ursodeoxycholic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA.
Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Biopsy; Budesonide; Cholagogues and Choleretics; Disease Progression; Double-Blind Method; Drug Monitoring; Female; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 2021 |
Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
Topics: Atherosclerosis; Carotid Intima-Media Thickness; Female; Humans; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Ursodeoxycholic Acid | 2021 |
Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial.
Topics: Adult; Cholagogues and Choleretics; Double-Blind Method; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Taurochenodeoxycholic Acid; Treatment Outcome; Ursodeoxycholic Acid | 2013 |
NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Manometry; Maximum Tolerated Dose; Middle Aged; Nitrates; Nitric Oxide Donors; Portal Pressure; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Failure; Ursodeoxycholic Acid | 2010 |
[Effect of Ursodeoxycholi acid on liver cirrhosis with hepatitis B].
Topics: Adult; Aged; Alkaline Phosphatase; Female; gamma-Glutamyltransferase; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Ursodeoxycholic Acid | 2010 |
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.
Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid | 2003 |
Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial.
Topics: Adult; Aged; Budesonide; Drug Therapy, Combination; Glucocorticoids; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Middle Aged; Prospective Studies; Ursodeoxycholic Acid | 2005 |
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
Topics: Adolescent; Adult; Aged; Biopsy; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Transaminases; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E; Vitamins | 2006 |
[The effect of ursodeoxycholic acid in patients with liver cirrhosis and chronic hypertransaminasemia].
Topics: Adult; Aged; Confidence Intervals; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Regression Analysis; Transaminases; Ursodeoxycholic Acid | 1994 |
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Topics: Alkaline Phosphatase; Bile Acids and Salts; Cholestasis; Chronic Disease; Down-Regulation; Female; gamma-Glutamyltransferase; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis; Male; Middle Aged; Selenium Radioisotopes; Taurocholic Acid; Up-Regulation; Ursodeoxycholic Acid | 1996 |
Effect of niuche-shen-qi-wan on painful muscle cramps in patients with liver cirrhosis: a preliminary report.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Diuretics; Drugs, Chinese Herbal; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Cramp; Plant Extracts; Plants, Medicinal; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex | 1997 |
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Topics: Adult; Aged; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Middle Aged; Penicillamine; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
A paucity of unusual trihydroxy bile acids in the urine of patients with severe liver diseases.
Topics: Acute Disease; Adolescent; Adult; Aged; Cholagogues and Choleretics; Cholic Acids; Female; Hepatitis; Humans; Liver Cirrhosis; Male; Middle Aged; Reference Values; Severity of Illness Index; Ursodeoxycholic Acid | 1999 |
A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cholagogues and Choleretics; Clinical Enzyme Tests; Female; Heart Rate; Hemodynamics; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Stroke Volume; Ursodeoxycholic Acid; Vascular Resistance | 1999 |
Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholagogues and Choleretics; Female; gamma-Glutamyltransferase; Genotype; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Placebos; Prednisone; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.
Topics: Disease Progression; Double-Blind Method; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Markov Chains; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2000 |
84 other study(ies) available for ursodeoxycholic acid and Cirrhosis, Liver
| Article | Year |
|---|---|
Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Cell Line; Cell Proliferation; Chemistry, Pharmaceutical; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Lipids; Liver; Liver Cirrhosis; Liver Function Tests; Male; Mice; Mice, Inbred ICR; Nanostructures; Particle Size; Pentacyclic Triterpenes; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Surface Properties; Ursodeoxycholic Acid | 2021 |
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study.
Topics: Bile Acids and Salts; Biopsy; Fibrosis; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Ursodeoxycholic Acid | 2022 |
Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Bile Acids and Salts; Cholestasis; Fibrosis; Inflammation; Interleukin-6; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Pyridones; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2022 |
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC.
Topics: Cholangitis, Sclerosing; Female; Humans; Liver Cirrhosis; Liver Diseases; Male; Quality of Life; Surveys and Questionnaires; Ursodeoxycholic Acid | 2023 |
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.
Topics: COVID-19; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Retrospective Studies; SARS-CoV-2; Ursodeoxycholic Acid | 2023 |
A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
Topics: Adult; Bile Acids and Salts; Child; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis; Mutation; Ursodeoxycholic Acid; Young Adult | 2023 |
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis.
Topics: Adult; Biopsy; Disease Progression; Elasticity Imaging Techniques; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pioglitazone; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Ursodeoxycholic Acid | 2019 |
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response.
Topics: Adult; Biomarkers, Pharmacological; Biopsy; Cohort Studies; Disease Progression; Female; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Prognosis; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.
Topics: Animals; Autophagy; Blotting, Western; Cell Line; Disease Models, Animal; Humans; Hydroxychloroquine; Hydroxyproline; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Ursodeoxycholic Acid | 2020 |
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.
Topics: Adult; Aged; Alkaline Phosphatase; Cholagogues and Choleretics; Chronic Disease; Databases, Factual; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Numbers Needed To Treat; Proportional Hazards Models; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Ursodesoxycholic acid alleviates liver fibrosis via proregeneration by activation of the ID1-WNT2/HGF signaling pathway.
Topics: Animals; Disease Models, Animal; Hepatocyte Growth Factor; Inhibitor of Differentiation Protein 1; Liver Cirrhosis; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Signal Transduction; Ursodeoxycholic Acid; Wnt Proteins | 2021 |
Possible gasoline-induced chronic liver injury due to occupational malpractice in a motor mechanic: a case report.
Topics: Automobiles; Cholagogues and Choleretics; Directive Counseling; Diuretics; Furosemide; Gasoline; Gastrointestinal Agents; Hepatomegaly; Humans; Hydrocarbons; Lactulose; Liver Cirrhosis; Male; Malpractice; Occupational Diseases; Occupational Exposure; Spironolactone; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2017 |
Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Drug Therapy, Combination; Female; Hepatocytes; Liver; Liver Cirrhosis; Malondialdehyde; Peroxidase; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Silybum marianum; Stem Cells; Ursodeoxycholic Acid | 2017 |
The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats.
Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile Acids and Salts; Bilirubin; Biomarkers; Collagen Type III; Collagen Type IV; Female; gamma-Glutamyltransferase; Gene Expression; Hyaluronic Acid; Laminin; Liver; Liver Cirrhosis; Liver Function Tests; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid | 2018 |
Autoimmune Pancreatitis and Ulcerative Rectocolitis in an Adolescent.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Biopsy; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholestasis; Diagnosis, Differential; Humans; Immunoglobulin G; Immunosuppressive Agents; Liver Cirrhosis; Male; Pancreatic Neoplasms; Pancreatitis; Proctocolitis; Ultrasonography; Ursodeoxycholic Acid | 2018 |
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
Topics: Aged; Antidepressive Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cohort Studies; Databases, Factual; Depression; Disease-Free Survival; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Mianserin; Middle Aged; Mirtazapine; Proportional Hazards Models; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Pediatric cirrhotic cardiomyopathy: Impact on liver transplant outcomes.
Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Echocardiography; Electrocardiography; End Stage Liver Disease; Female; Humans; Incidence; Infant; Length of Stay; Liver Cirrhosis; Liver Transplantation; Male; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Vitamin A can ameliorate fibrosis of liver in an established rat model of biliary atresia and Kasai portoenterostomy.
Topics: Animals; Biliary Atresia; Biomarkers; Cholagogues and Choleretics; Disease Models, Animal; Glucocorticoids; Immunohistochemistry; Liver; Liver Cirrhosis; Portoenterostomy, Hepatic; Prednisolone; Rats; Rats, Sprague-Dawley; Treatment Outcome; Ursodeoxycholic Acid; Vitamin A | 2018 |
Analysis of predictive response scores to treatment with ursodeoxycholic acid in patients with primary biliary cholangitis.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Area Under Curve; Body Mass Index; Cholesterol; Comorbidity; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Retrospective Studies; ROC Curve; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Prevalence; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2018 |
Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Cholesterol; Cholic Acids; Diet, Western; Dietary Supplements; Fibrosis; Gallbladder; Hypolipidemic Agents; Liver; Liver Cirrhosis; Male; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Spirulina; Superoxides; Thiobarbituric Acid Reactive Substances; Ursodeoxycholic Acid | 2019 |
Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
Topics: Actins; Animals; Anti-Inflammatory Agents; Cell Line; Collagen Type I; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Lysophospholipids; Male; Mice, Inbred C57BL; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1; Ursodeoxycholic Acid; Vimentin | 2014 |
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
Topics: Animals; Cholagogues and Choleretics; Disease Models, Animal; Drug Monitoring; Granuloma; Immunohistochemistry; Inflammation; Liver Cirrhosis; Lymphocyte Activation; Mice; Schistosomiasis mansoni; T-Lymphocytes; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Topics: Antigens, Neoplasm; Case-Control Studies; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Membrane Glycoproteins; Middle Aged; Plant Lectins; Prognosis; Proportional Hazards Models; Receptors, N-Acetylglucosamine; Retrospective Studies; Ursodeoxycholic Acid | 2015 |
Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child.
Topics: Afibrinogenemia; Carbamazepine; Child, Preschool; Cholagogues and Choleretics; Cytochrome P-450 CYP3A Inducers; Female; Fibrinogen; Humans; Hypobetalipoproteinemias; Liver; Liver Cirrhosis; Mutation, Missense; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Cytokines; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endotoxins; Inflammation Mediators; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4; Ursodeoxycholic Acid | 2016 |
Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis.
Topics: Analysis of Variance; Body Mass Index; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Liver Cirrhosis; Male; Nutritional Status; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Ultrasonography; Ursodeoxycholic Acid | 2015 |
Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Animals; Autophagy; Cells, Cultured; Deoxycholic Acid; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Liver; Liver Cirrhosis; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phenotype; Transfection; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients.
Topics: Adolescent; Child; Cholagogues and Choleretics; Cystic Fibrosis; Drug Monitoring; Elasticity Imaging Techniques; Female; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Netherlands; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2016 |
Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
Topics: Adolescent; Adult; Aged; Cholangiography; Cholangitis, Sclerosing; Disease Progression; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Middle Aged; Prognosis; Retrospective Studies; Syndrome; Ursodeoxycholic Acid; Young Adult | 2009 |
Post-liver transplant cholestatic disorder with biliary strictures: de novo versus recurrent primary sclerosing cholangitis.
Topics: Aged; Anti-Inflammatory Agents; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Cirrhosis; Liver Transplantation; Male; Postoperative Complications; Prednisone; Ursodeoxycholic Acid | 2009 |
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Topics: Adenosine Triphosphatases; Alanine Transaminase; alpha-Fetoproteins; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Child; Child, Preschool; Cholestasis, Intrahepatic; gamma-Glutamyltransferase; Humans; Infant; Liver; Liver Cirrhosis; Phenotype; Retrospective Studies; Ursodeoxycholic Acid | 2010 |
[Alagille syndrome diagnosed in adolescence: a case report].
Topics: Adolescent; Alagille Syndrome; Cholagogues and Choleretics; Esophageal and Gastric Varices; Hematemesis; Humans; Liver Cirrhosis; Male; Ursodeoxycholic Acid | 2010 |
Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Proliferation; Diet, Fat-Restricted; Disease Progression; Down-Regulation; Drug Evaluation, Preclinical; Fatty Liver; Hepatocytes; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Liver Cirrhosis; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Ursodeoxycholic Acid | 2011 |
Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.
Topics: Adolescent; Alleles; Child; Child, Preschool; Cholestasis, Intrahepatic; Codon, Nonsense; Disease Progression; Exons; Female; Frameshift Mutation; gamma-Glutamyltransferase; Genotype; Humans; Infant; Italy; Liver Cirrhosis; Male; Phenotype; Polymorphism, Single Nucleotide; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Ursodeoxycholic Acid | 2011 |
[Gastroenterology and hepatology. Using established therapies].
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Evidence-Based Medicine; Fatty Liver, Alcoholic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Mesalamine; Ursodeoxycholic Acid; Weight Loss | 2010 |
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cell Proliferation; Cholestasis, Intrahepatic; Chronic Disease; Dietary Fats; Disease Models, Animal; Disease Progression; Fatty Acids; Female; Fenofibrate; Gene Expression Profiling; Gene Expression Regulation; Hepatitis; Hypolipidemic Agents; Lipid Metabolism; Liver; Liver Cirrhosis; Metabolomics; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Triglycerides; Ursodeoxycholic Acid | 2012 |
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
Topics: Aged; Alanine Transaminase; Azathioprine; Biomarkers; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Mechanism and significance of changes in glutamate-cysteine ligase expression during hepatic fibrogenesis.
Topics: Animals; Base Sequence; Cells, Cultured; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Glutamate-Cysteine Ligase; Hepatic Stellate Cells; Liver Cirrhosis; MafG Transcription Factor; Molecular Sequence Data; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Repressor Proteins; Response Elements; S-Adenosylmethionine; SUMO-1 Protein; Sumoylation; Ursodeoxycholic Acid | 2012 |
Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats.
Topics: Animals; Antioxidants; Artemisia; Cholagogues and Choleretics; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Liver Cirrhosis; Liver Function Tests; Male; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid | 2013 |
Long-term combined therapy with very-low-dose peginterferon and ursodeoxycholic acid decreased the spleen size in a patient with hepatitis C virus-related cirrhosis.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Interferon-alpha; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Spleen; Ursodeoxycholic Acid | 2013 |
Prevention and treatment of intestinal failure-associated liver disease in children.
Topics: Cholagogues and Choleretics; Cholestasis; Fat Emulsions, Intravenous; Fatty Liver; Humans; Intestinal Diseases; Liver Cirrhosis; Liver Diseases; Parenteral Nutrition; Ursodeoxycholic Acid | 2012 |
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
Topics: Acute Disease; Adult; Bile Duct Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Hepatitis; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver.
Topics: Adipocytes; Animals; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Nitrates; Nitric Oxide; Ursodeoxycholic Acid | 2003 |
Effects of the herbal medicine Inchinko-to on liver function in postoperative patients with biliary atresia--a pilot study.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Biliary Atresia; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Hyaluronic Acid; Liver; Liver Cirrhosis; Male; Pilot Projects; Postoperative Complications; Taurine; Ursodeoxycholic Acid | 2003 |
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver.
Topics: Animals; Bile; Blood Pressure; Drug Interactions; Hypertension, Portal; In Vitro Techniques; Liver Circulation; Liver Cirrhosis; Male; Nitrates; Nitric Oxide Donors; Norepinephrine; Perfusion; Rats; Rats, Wistar; Ursodeoxycholic Acid; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2003 |
A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats.
Topics: Animals; Drug Interactions; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Methoxamine; Nitrates; Nitric Oxide Donors; Portal Vein; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid; Vascular Resistance; Vasoconstrictor Agents | 2003 |
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Topics: Aspartate Aminotransferases; Bile Ducts, Intrahepatic; Bilirubin; Biomarkers; Cholagogues and Choleretics; Female; Humans; Hyaluronic Acid; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Lymphocytes; Male; Middle Aged; Necrosis; Predictive Value of Tests; Sensitivity and Specificity; Ursodeoxycholic Acid | 2004 |
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Topics: Alanine Transaminase; Analysis of Variance; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepacivirus; Hepatitis C; Humans; Incidence; Inflammation; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Cholagogues and Choleretics; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Remission Induction; Ursodeoxycholic Acid | 2007 |
A single centre experience of liver disease in adults with cystic fibrosis 1995-2006.
Topics: Adult; Cholagogues and Choleretics; Comorbidity; Cystic Fibrosis; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Platelet Count; Prospective Studies; Splenomegaly; Thrombocytopenia; Ursodeoxycholic Acid | 2008 |
Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
Topics: Adult; Aged; Alkaline Phosphatase; Antibodies, Antinuclear; Area Under Curve; Biopsy, Needle; Cholagogues and Choleretics; Elasticity Imaging Techniques; Female; Fibrosis; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prospective Studies; ROC Curve; Ursodeoxycholic Acid | 2008 |
Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Endoplasmic Reticulum; Hepatocytes; Liver Cirrhosis; Male; Microscopy, Electron, Transmission; Organelles; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid | 2008 |
Portal-systemic spill-over of bile acids: a study of mechanisms using ursodeoxycholic acid.
Topics: Adult; Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Female; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1983 |
Influence of esophageal transection for esophageal varices on serum bile acid level.
Topics: Adult; Aged; Bile Acids and Salts; Esophageal and Gastric Varices; Esophagus; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Time Factors; Ursodeoxycholic Acid | 1984 |
[Significance and limitations of oral UDCA loading in liver function test].
Topics: Bile Acids and Salts; Biological Availability; Deoxycholic Acid; Diagnosis, Differential; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Ursodeoxycholic Acid | 1984 |
Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
Topics: Adolescent; Adult; Bile Acids and Salts; Catheterization; Deoxycholic Acid; Fasting; Female; Hemodynamics; Humans; Liver; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Portal System; Portasystemic Shunt, Surgical; Splenic Vein; Ursodeoxycholic Acid | 1984 |
Oral ursodeoxycholic acid tolerance test in patients with digestive disease.
Topics: Adult; Bile Acids and Salts; Deoxycholic Acid; Digestive System Diseases; Female; Hepatitis; Humans; Intestinal Diseases; Liver Cirrhosis; Male; Ursodeoxycholic Acid | 1981 |
[Liver cirrhosis in protoporphyria: bile acid therapy and liver transplantation].
Topics: Adult; Cholestasis, Intrahepatic; Combined Modality Therapy; Follow-Up Studies; Humans; Liver Cirrhosis; Liver Transplantation; Male; Porphyria, Hepatoerythropoietic; Protoporphyrins; Ursodeoxycholic Acid | 1995 |
Two cases from the spectrum of nonalcoholic steatohepatitis.
Topics: Adult; Aged; Biopsy; Fatty Liver; Female; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Obesity; Ursodeoxycholic Acid | 1995 |
A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency.
Topics: Alanine Transaminase; Bile Acids and Salts; Bilirubin; Child; Child, Preschool; Cholestasis, Intrahepatic; Cholesterol; Follow-Up Studies; gamma-Glutamyltransferase; Hepatitis; Humans; Infant; Liver; Liver Cirrhosis; Multienzyme Complexes; Progesterone Reductase; Retrospective Studies; Steroid Isomerases; Ursodeoxycholic Acid; Vitamin E | 1994 |
A 20-year-old woman with portal hypertension and a cholestatic syndrome.
Topics: Adult; Biopsy; Cholestasis; Diagnosis, Differential; Female; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Prognosis; Ursodeoxycholic Acid | 1994 |
[Detection of bile acid N-acetylglucosaminides in serum and urine during administration of ursodeoxycholic acid].
Topics: Acetylglucosamine; Bile Acids and Salts; Chromatography, High Pressure Liquid; Humans; Liver Cirrhosis; Ursodeoxycholic Acid | 1994 |
Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.
Topics: Adolescent; Adult; Cause of Death; Child; Cystic Fibrosis; Female; Follow-Up Studies; Heart-Lung Transplantation; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Transplantation; Male; Portacaval Shunt, Surgical; Splenectomy; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1993 |
Prognostic significance of portal hemodynamics in patients with compensated cirrhosis.
Topics: Adult; Aged; Blood Flow Velocity; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Portal System; Portal Vein; Probability; Prognosis; Proportional Hazards Models; Regional Blood Flow; Serum Albumin; Survival Analysis; Ultrasonography; Ursodeoxycholic Acid | 1993 |
Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report.
Topics: Adult; Female; Gastrointestinal Agents; Genotype; Hepacivirus; Hepatitis B; Hepatitis C; Humans; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Ursodeoxycholic Acid | 1996 |
Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
Topics: Acute Disease; Adult; Bile Duct Diseases; Biopsy; Child; Cholestasis; Female; Humans; Ibuprofen; Liver; Liver Cirrhosis; Prednisone; Stevens-Johnson Syndrome; Tacrolimus; Time Factors; Ursodeoxycholic Acid | 1998 |
Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
Topics: Adult; Aged; Analysis of Variance; Antioxidants; Ascites; Contraindications; Female; Forearm; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Sodium; Ursodeoxycholic Acid | 1999 |
Assessment of biliary bicarbonate secretion in humans by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Bicarbonates; Bile Ducts; Biliary Tract Diseases; Cholestasis, Extrahepatic; Female; Gastrointestinal Agents; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Reference Values; Secretin; Sodium Bicarbonate; Tomography, Emission-Computed; Ursodeoxycholic Acid | 1999 |
Time course of histological progression in primary sclerosing cholangitis.
Topics: Adolescent; Adult; Aged; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Disease Progression; Female; Follow-Up Studies; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Markov Chains; Middle Aged; Necrosis; Penicillamine; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Drugs, Chinese Herbal; Female; Glycyrrhizic Acid; Hepatitis C; Hepatitis C, Chronic; Humans; Injections, Intramuscular; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Procollagen; Retrospective Studies; RNA, Viral; Ursodeoxycholic Acid | 2000 |
3beta-hydroxy-delta5-C27-steroid dehydrogenase/isomerase deficiency in a 23-year-old woman.
Topics: 3-Hydroxysteroid Dehydrogenases; Adult; Chenodeoxycholic Acid; Cholic Acid; Female; Humans; Liver; Liver Cirrhosis; Metabolism, Inborn Errors; Steroid Isomerases; Ursodeoxycholic Acid; Vitamin K Deficiency | 2000 |
Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis.
Topics: Adult; Aged; Aspartate Aminotransferases; Bile Acids and Salts; Cholic Acids; Female; gamma-Glutamyltransferase; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 2001 |
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.
Topics: Animals; Carbon Tetrachloride; Collagen; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Nitrates; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Wistar; Salicylates; Ursodeoxycholic Acid | 2001 |
Beta-carotene-induced hepatic fibrosis.
Topics: Aged; Alcoholism; beta Carotene; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis; Retinitis Pigmentosa; Ursodeoxycholic Acid | 2002 |
Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.
Topics: Chronic Disease; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Silymarin; Ursodeoxycholic Acid | 1992 |
[Factors influencing the effect of ursodeoxycholic acid therapy in chronic hypertransaminasemia].
Topics: Adult; Aged; Chronic Disease; Clinical Enzyme Tests; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Regression Analysis; Transaminases; Ursodeoxycholic Acid | 1992 |
[Effect of ursodeoxycholic acid (UDCA) therapy for compensatory liver cirrhosis on liver function tests and serum bile acid metabolism].
Topics: Adult; Aged; Bile Acids and Salts; Drug Administration Schedule; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 1992 |
Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Chromatography, Gas; Deoxycholic Acid; Gas Chromatography-Mass Spectrometry; Humans; Hydroxy Acids; Liver Cirrhosis; Rifampin; Ursodeoxycholic Acid | 1990 |
[Erythrohepatic protoporphyria with rapidly progressing liver cirrhosis].
Topics: Cholestyramine Resin; Humans; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Porphyrias; Porphyrins; Protoporphyrins; Sepsis; Ursodeoxycholic Acid | 1989 |
[Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
Topics: Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Glucagon; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Predictive Value of Tests; Ursodeoxycholic Acid | 1988 |
A combination therapy of vitamin K1 and bile acid on hemorrhagic diathesis in patients with decompensated liver cirrhosis.
Topics: Chenodeoxycholic Acid; Deoxycholic Acid; Drug Therapy, Combination; Female; Hemorrhagic Disorders; Humans; Liver Cirrhosis; Male; Ursodeoxycholic Acid; Vitamin K | 1988 |
Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.
Topics: Adult; Aged; Bile Acids and Salts; Deoxycholic Acid; Esophageal and Gastric Varices; Esophagoscopy; Female; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid | 1987 |
[Bile acids in chronic hepatopathies].
Topics: Adult; Bile Acids and Salts; Cholestasis; Chronic Disease; Diagnosis, Differential; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Middle Aged; Ursodeoxycholic Acid | 1986 |